THERAPEUTICAL USE OF TERNARY COMPLEXES OF VALPROIC ACID
A method of treating a human subject having a condition responsive to valproic acid therapy, includes administering to the subject an effective amount of a metal-based ternary complex of valproic acid with nitrogen donor ligands, in particular with diimines or diamines.
-
Figure 1
(2012/06/16)
Chemical Properties
Appearance/Colour :White powder
Boiling Point: 220 °C at 760 mmHg
Flash Point:116.6 °C
Solubility:Ethyl Acetate (Slightly), Methanol (Slightly), Water (Slightly)
